Back to Top Skip to main content the official website of the Military Health System (MHS) and the Defense Health Agency (DHA)

Utility Navigation Links

Alert Arrow ALERT!!

WEEKEND MAINTENANCE: The maintenance outage is scheduled for Friday night, December 2nd until Sunday, December 4th. The TRICARE Manuals web site may be available intermittently during this period but it's usage is not recommended.

We are aware of the issue with the 32 CFR 199 cross-references (Table of Contents links) and are working to resolve the issue. Thank you.

TRICARE Reimbursement Manual 6010.61-M, April 1, 2015
Mental Health
Chapter 7
Section 5
Opioid Treatment Programs (OTPs) Reimbursement
Issue Date:  November 15, 2017
Copyright:  CPT only © 2006 American Medical Association (or such other date of publication of CPT). All Rights Reserved.
Revision:  C-10, November 15, 2017
1.1  This policy is mandatory for reimbursement of services provided by either network or non- network providers. However, alternative network reimbursement methodologies are permitted when approved by the Defense Health Agency (DHA) and specifically included in the network provider agreement.
1.2  The following reimbursement methodology shall be used for payment of freestanding OTPs and other providers who are exempt from the TRICARE Outpatient Prospective Payment System (OPPS) and provide OTP services.
2.0  ISSUE
Reimbursement of freestanding OTPs. Freestanding OTPs shall be reimbursed based on the variability in the dosage and frequency of the drug being administered and on related supportive services.
3.1  Freestanding methadone OTPs (which also provide opioid partial agonists and antagonists) shall be reimbursed the lower of the billed charge or a weekly all-inclusive rate.
3.1.1  The weekly all-inclusive rate shall include the cost of the drug and all related services (i.e., the costs related to initial intake/assessment, drug dispensing and screening, and integrated psychosocial and medical treatment and support services).
3.1.2  The weekly all-inclusive rate shall be accepted as payment-in-full.
3.1.3  The weekly all-inclusive rate is subject to the outpatient cost-sharing provisions in 32 CFR 199.4(f). Services shall be cost-shared on a weekly basis (e.g., one $12 cost-share applies to a full week of methadone OTP services for a Prime retiree).
3.1.4  The initial Fiscal Year (FY) 2017 national weekly all-inclusive rate is $126. This rate is based upon an estimated drug cost of $3 per day, and $15 per day for medical services. The national rate was determined to be $126 after an analysis of the payments made by other payers.
3.1.5  The weekly all-inclusive rate shall be wage-adjusted by the CHAMPUS Maximum Allowable Charge (CMAC) locality adjustment factors.
3.1.6  The national weekly all-inclusive rate shall be updated annually, on October 1 of each year, by the Medicare update factor used for the Medicare Inpatient Prospective Payment System (IPPS) (see Section 1, paragraph 3.5.3 for the list of update factors).
3.1.7  The weekly all-inclusive rate shall be posted to the DHA website by October 1 of each year. DHA shall retain three years of reimbursement rates for methadone OTPs on the DHA website.
3.1.8  The weekly all-inclusive set of services shall be billed utilizing Healthcare Common Procedure Coding System (HCPCS) code H0020 [Alcohol and/or drug services]. Only one occurrence of this code shall be reimbursed in a given week (seven day period). Services that are incorporated into the weekly all-inclusive rate (e.g., HCPCS code J1230 for the methadone) shall not be separately reimbursed.
3.1.9  Psychotherapy sessions and non-mental health related medical services not normally included in the evaluation and assessment for OTPs, provided by authorized independent providers who are not employed by, or under contract with, the OTP for the purposes of providing clinical patient care are not included in the weekly bundled rate and may be billed separately. This includes ambulance services when medically necessary for emergency transport.
3.2  OTP reimbursement of other medications (e.g., buprenorphine and naltrexone) provided in freestanding OTPs shall be made on a fee-for-service basis (i.e., separate payments will be allowed for both the medication and accompanying support services).
3.2.1  Buprenorphine. HCPCS code H0047 shall be utilized to reflect the medical intake and assessment, drug dispensing and monitoring, and counseling services. H0047 shall be reimbursed in accordance with the CMAC methodology; see Chapter 5, Section 3. The appropriate HCPCS code shall be utilized to bill for the medication. The National Drug Code (NDC) shall be reported to the contractor, along with the dosage and acquisition cost. The drug shall be reimbursed in accordance with the Chapter 1, Section 15.
3.2.2  Naltrexone. HCPCS code H0047 shall be utilized to reflect the medical intake and assessment, monitoring and counseling services. Current Procedural Terminology (CPT) code 96372 shall be utilized to report the administration fee. H0047 and 96372 shall be reimbursed in accordance with the CMAC methodology; see Chapter 5, Section 3. HCPCS code J2315 shall be utilized for the prescribed medication, along with the number of milligrams used. The drug shall be reimbursed in accordance with Chapter 1, Section 15. In general, naltrexone is provided as an injection every four weeks. Contractors shall review more frequent administration to ensure services are medically necessary and appropriate.
3.2.3  Participation Agreement  In order for the services of an OTP to be authorized, the OTP must sign a Participation Agreement. See the TRICARE Policy Manual (TPM), Chapter 11, Addendum H.  The agreement requires the OTP to accept the TRICARE determined rate as payment in full and collect from the beneficiary or the family of the beneficiary those amounts that represent the beneficiary’s liability, as defined by 32 CFR 199, and charges for services and supplies that are not a benefit.
3.2.4  Cost-Sharing
Services provided under paragraph 3.2 are subject to the outpatient cost-sharing provisions in 32 CFR 199.4(f). Cost-sharing shall be applied on a per-visit basis.
October 3, 2016.
- END -

Utility Navigation Links

DoD Seal is the official website of the Defense Health Agency (DHA) a component of the Military Health System

TRICARE is a registered trademark of the Department of Defense (DoD), DHA. All rights reserved.

CPT only © 2006 American Medical Association (or such other date of publication of CPT). All Rights Reserved.

If you have a question regarding TRICARE benefits, please go to the TRICARE Contact Us page page.
If you need help with technical/operational issues, please go to the TRICARE Manuals Online Frequently Asked Questions page.

The appearance of hyperlinks to external websites does not constitute endorsement by the DHA of these websites or the information, products or services contained therein. For other than authorized government activities, the DHA does not exercise any editorial control over the information you may find at other locations. Such links are provided consistent with the stated purpose of this DoD website.


DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.